FEB 02, 2016 7:13 AM PST

First License to Genetically Edit Human Embryos Granted

WRITTEN BY: Xuan Pham
Embryonic development from single cell (top left) to blastocyst (bottom right).

In a historic, unprecedented move, UK national fertility regulators have given the green light for scientists to use the new CRISPR-cas9 gene-editing tool to manipulate human embryos. The approval stirred up big waves amongst the scientific community, as many leading nations are still observing a voluntarily moratorium to halt gene-editing in human embryonic cells.
 
 
Kathy NiakanThe research application, which was approved by the Human Fertilization and Embryology Authority (HFEA), outlined the use of CRISPR-cas9 to study how human embryonic development happens. Dr. Kathy Niakan leads this research endeavor. She explained that her research could help scientists better understand fertility and possibility solve infertility. 
 

We would really like to understand the genes needed for a human embryo to develop successfully into a healthy baby. The reason why it is so important is because miscarriages and infertility are extremely common, but they're not very well understood. – Dr. Niakan

There’s one major stipulation of the approval: the scientists cannot implant the edited embryos into any wombs, not that Dr. Niakan was planning to anyways. Her research will focus on the genetic changes in the embryos in the first several days of development. After seven days, the experiments will stop and the embryos will be destroyed.
 
This clause clearly stems from scientists’ uncertainties over the consequences of modifying human germ cells and early embryos. Unlike conventional gene therapies that target other cells in the body, gene editing in germ cells (sperm and egg) or early embryos has the potential to affect the genetics of future generations. That means genetic alterations could be passed on to children and even grandchildren. Because of the relative low cost and high efficiency of CRISPR/Cas9, gene manipulation in these precarious cells has never been easier. And this makes many people quite uneasy.
 
Some people applaud the landmark approval, noting that the decision struck a balance between scientific progress and ethical considerations.

Dr Niakan's proposed research is important for understanding how a healthy human embryo develops and will enhance our understanding of IVF success rates, by looking at the very earliest stage of human development. – Paul Nurse, the director of the Crick Institue.

"This decision is a victory for level-headed regulation over moral panic," added Sarah Norcross, director of the Progress Educational Trust.

Still, some think we may be dangerously close to crossing the line of unethical genetic manipulations.

So this is the first step in a well mapped-out process leading to GM babies, and a future of consumer eugenics. – Dr. David King, the director of Human Genetics Alert

How do you, readers, weigh in?

Sources: Nature News, New York Times, BBC
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUL 20, 2019
Clinical & Molecular DX
JUL 20, 2019
Diagnosing Autism, The Child-Friendly Way
The term autism spectrum disorder ASD is an umbrella term for a wide range of conditions. These conditions are characterized by difficulty in social situat...
JUL 25, 2019
Clinical & Molecular DX
JUL 25, 2019
Tinea Versicolor, Diagnosis And Treatment
Tinea Versicolor (TV) is a fungal infection of the skin. Also called Pityriasis Versicolor, the condition is common, especially in tropical climates. The d...
SEP 05, 2019
Clinical & Molecular DX
SEP 05, 2019
Muscular Dystrophy Drug by Sarepta Therapeutics: Approval or Rejection by Drug Regulating Authorities?
Duchenne Muscular Dystrophy (DMD is a rare, genetic disorder that hampers muscle movement and is the most common pediatric muscular dystrophy. I...
NOV 02, 2019
Clinical & Molecular DX
NOV 02, 2019
Forecasting Chronic Pain
Chronic pain comes in many forms. Over half of those suffering from chronic pain, say they experience life-altering levels of pain on a daily basis. Many s...
JAN 07, 2020
Clinical & Molecular DX
JAN 07, 2020
Kiss and tell: new test for kissing bug disease
Here’s one Latin lover that you do not want to get kissed by: triatomines, or “kissing bugs”. Known locally as pitos or chipos, these ins...
JAN 14, 2020
Clinical & Molecular DX
JAN 14, 2020
Can I eat this donut? A quick test for celiac disease.
Genetic testing revealed that our ancestors have been eating wheat, rye, spelt and barley for over 8,000 years. Today, gluten, a protein found within these...
Loading Comments...